MEDRAD, Inc. a business of Bayer Medical Care has received FDA clearance* to market the MEDRAD Intego PET Infusion System (Intego) for Sodium Fluoride (F18-NaF) administration in Positron Emission Tomography (PET) imaging.
Read More

Bayer Medical Care announced today the appointment of Samuel M. Liang as incoming president and chief executive officer of MEDRAD, Inc., upon the retirement of John Friel later this year.
Read More

MEDRAD, Inc. Multi Vendor Service has announced the opening of a repair facility in Denver, Colorado that specializes in 3D/4D ultrasound probes.
Read More

Today, MEDRAD, Inc. announced plans to demonstrate PACS injection-record integration capabilities at the November 2009 RSNA. Connect.PACS™ product is the latest release in the company’s newly branded Certegra™ Informatics Platform.
Read More

MEDRAD, Inc. has signed a research agreement with the University of South Florida (USF) to study the impact of automated Fluoro-deoxy-glucose (FDG) administration on the workflow for Positron Emission Tomography (PET) imaging procedures.
Read More

MEDRAD's P3T™ Cardiac CT application was selected to be showcased at the Premier healthcare alliance’s first annual Innovation Celebration.
Read More

Manage.Report is an informatics application that enables healthcare professionals to immediately access clinical and administrative information associated with radiology patients’ contrast injections from nearly anywhere.
Read More